Stem Cell Banking Market, By Source Type (Umbilical Cord Stem Cell, Adult Stem Cell, Embryonic Stem Cell), By Service Type (Collection and Transportation, Processing, Analysis, Storage), By Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI1354

Pages :148

Formats :

Excel and PDF

Industry : Biotechnology

Stem Cell Banking Market Size and Trends

Global stem cell banking market is estimated to be valued at USD 6.50 Bn in 2025 and is expected to reach USD 17.00 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Stem Cell Banking Market Key Factors

To learn more about this report, Request sample copy

Global stem cell banking market is witnessing growth due to growing awareness about the therapeutic potential of stem cells. Increasing investment by government and private companies in R&D activities for developing novel stem cell therapy and drugs also drives the market growth. Advancements in regenerative medicines using stem cells offer lucrative opportunities for market players. Moreover, rising focus on personalized medicine boosts demand for private and public cord blood banking services.

Increasing Research and Development for the Treatment of Diseases

Increasing research and development for the treatment of diseases is expected to propel the market growth. For instance, on May 9, 2022, Xintela, a company that develops medical products in stem cell therapy and targeted cancer therapy, announced the result of study conducted for the company’s stem cell product XSTEM, after injection into a joint with damaged cartilage, and develop into cartilage cells and directly contribute to producing new cartilage tissue. This demonstrates that XSTEM has excellent potential to be a DMOAD (Disease Modifying Osteoarthritis Drug), a treatment that can prevent further degradation of the cartilage in osteoarthritis patients.